Health Alert Issued As DRAP Recalls Faulty Auto-Disable Syringes

Islamabad: (Web Desk) The Drug Regulatory Authority of Pakistan has issued a medical product alert after declaring multiple batches of auto-disable syringes manufactured by six local and international companies as substandard. The regulator said affected 3ml and 5ml syringes failed to meet required quality and safety standards.

According to DRAP, laboratory testing conducted by the Central Drugs Laboratory in Karachi revealed that several sampled batches did not comply with auto-disable functionality requirements. The defective products included syringes manufactured by Jiangxi Fenglin Medical Appliances, Medila Elwakia International Company, and Shandong Care Medical, along with products supplied by manufacturers based in Punjab and Khyber Pakhtunkhwa.

The regulator warned that faults in the auto-disable mechanism could allow syringes to be reused, creating a significant public health threat. Reuse of syringes can increase the risk of transmitting dangerous infectious diseases, including Hepatitis and HIV.

Pakistan Australia Set For Decisive Lahore ODI Clash

DRAP has prohibited the sale, distribution, and use of the affected batches and instructed provincial health authorities to immediately remove the products from the market. Manufacturers, importers, and distributors have also been directed to initiate urgent recall procedures to prevent further circulation of the substandard syringes.

Health officials emphasized that swift action is necessary to protect patients and maintain the safety of medical supplies across the country.